(secondQuint)Anti-psychotic Medication (New Use) Weight Loss Study.

 A total of 30 subjects will be enrolled in this study.

 They will be randomized in to one of two groups.

 One group (of 20 subjects) will take 500 mg of the investigational product (IHBG-10) 15 minutes prior to the three main meals of the day; subjects will continue to take their prescribed anti-psychotic medications.

 The other group (of 10 subjects) will take a placebo 15 minutes prior to the three main meals of the day; subjects will continue to take their prescribed anti-psychotic medications.

 Subjects will take the investigational product or placebo for 12 weeks.

 Participation in this study involves 4 study visits.

.

 Anti-psychotic Medication (New Use) Weight Loss Study@highlight

This is a pilot study to determine the safety and efficacy of an investigational product (IHBG-10) on weight change and changes in body composition in subjects who have just started taking (for less than three months) certain anti-psychotic medications (Risperdal, Seroquel, and/or Zyprexa).

